Français
ItalianoBond Gilead Sciences 4.8% ( US375558CB72 ) in USD
| Issuer | Gilead Sciences | ||||||||||||||||||||
| Market price |  99.85 % ▼ |
||||||||||||||||||||
| Country |  United States
|
||||||||||||||||||||
| ISIN code |
 US375558CB72 ( in USD )
|
||||||||||||||||||||
| Interest rate | 4.8% per year ( payment 2 times a year) | ||||||||||||||||||||
| Maturity | 15/11/2029 | ||||||||||||||||||||
|
Prospectus brochure in PDF format |
|||||||||||||||||||||
| Minimal amount | 2 000 USD | ||||||||||||||||||||
| Total amount | 750 000 000 USD | ||||||||||||||||||||
| Cusip | 375558CB7 | ||||||||||||||||||||
| Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) | ||||||||||||||||||||
| Moody's rating | A3 ( Upper medium grade - Investment-grade ) | ||||||||||||||||||||
| Next Coupon | 15/11/2026 ( In 81 days ) | ||||||||||||||||||||
| Detailed description |
Gilead Sciences is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, primarily in HIV/AIDS, viral hepatitis, and oncology. The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558CB72, pays a coupon of 4.8% per year. The coupons are paid 2 times per year and the Bond maturity is 15/11/2029 The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558CB72, was rated A3 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558CB72, was rated A- ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||||||||||||
| |||||||||||||||||||||